Status:
COMPLETED
Therapeutic Drug Monitoring of Voriconazole
Lead Sponsor:
Seoul National University Hospital
Conditions:
Mycoses
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether therapeutic drug monitoring of voriconazole is useful in the treatment of invasive fungal infection.
Detailed Description
Voriconazole is an anti-fungal agent, which is used in the treatment of invasive fungal infection, especially aspergillosis. The serious side effects of voriconazole include liver function abnormality...
Eligibility Criteria
Inclusion
- patients who were 16 years of age or older
- receiving voriconazole in order to treat invasive fungal infections or for empirical use
Exclusion
- who experienced the serious side effect of voriconazole
- were hypersensitive to azoles
- had an aminotransferase, bilirubin, or alkaline phosphatase level higher than five times the upper limit of normal
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00890708
Start Date
November 1 2008
End Date
February 1 2012
Last Update
February 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744